SCHEMBL5072182

SCHEMBL5072182

O=C(NCC1CC1)OCC1CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
PTGIR P43119 3/20 0.41
EPHX1 P07099 2/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
CA9 Q16790 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.36
CYP2D6 P10635 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13975689 0.86 TDP1 (0.39) TDP1PTGIREPHX1ALDH1A1CYP3A4
SCHEMBL13976142 0.85 ALDH1A1 (0.46) TDP1PTGIRALDH1A1NPC1RAB9A
SCHEMBL13367965 0.81 EPHX1 (0.48) TDP1PTGIREPHX1ALDH1A1LMNA
SCHEMBL8392106 0.81 TDP1 (0.48) TDP1EPHX1ALDH1A1CYP3A4CYP2C19
SCHEMBL13387503 0.81 TDP1 (0.48) TDP1EPHX1ALDH1A1CYP3A4CYP2C19
SCHEMBL11509871 0.79 ACHE (0.47) TDP1EPHX1ALDH1A1CYP3A4CA12
SCHEMBL206033 0.79 PTGIR (0.45) TDP1PTGIRALDH1A1LMNA
SCHEMBL12223164 0.78 MEN1 (0.50) EPHX1ALDH1A1
SCHEMBL7904682 0.77 TDP1 (0.54) TDP1EPHX1ALDH1A1CYP3A4CA12
SCHEMBL8290413 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931661-A1 ISOXAZOLO DERIVATIVES AS GABA A ALPHA5 INVERSE AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2008-06-18 EP disclosed
WO-2007039389-A1 ISOXAZOLO DERIVATIVES AS GABA A ALPHA5 INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-04-12 WO disclosed